Roger Kamm,
Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering,
Massachusetts Institute of Technology (MIT)
Kamm is currently the Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering at MIT, where he has served on the faculty since 1978. Kamm has long been instrumental in developing research activities at the interface of biology and mechanics, formerly in cell and molecular mechanics, and now in engineered living systems. Current interests are in developing models of healthy and diseased organ function using microfluidic technologies, with a focus on vascularization. Kamm has fostered biomechanics as Chair of the US National Committee on Biomechanics (2006-2009) and of the World Council on Biomechanics (2006-2010). Kamm currently directs the NSF Science and Technology Center on Emergent Behaviors of Integrated Cellular Systems. He is the 2010 recipient of the ASME Lissner Medal (American Society of Mechanical Engineering) and the 2015 recipient of the Huiskes Medal (European Society of Biomechanics), both for lifetime achievements, and is the inaugural recipient of the ASME Nerem Medal for mentoring and education. He was elected to the National Academy of Medicine in 2010. Kamm is co-founder of two companies, Cardiovascular Technologies and AIM Biotech, a manufacturer of microfluidic systems for 3D culture.
Microphysiological Models Relying on Emergence of Multi-Cellular Engineered Living Systems
Tuesday, 5 June 2018 at 11:15
Add to Calendar ▼2018-06-05 11:15:002018-06-05 12:15:00Europe/LondonMicrophysiological Models Relying on Emergence of Multi-Cellular Engineered Living SystemsLab-on-a-Chip and Microfluidics Europe 2018 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
Recent work from many labs has demonstrated the unique capability of
cells placed in 3D culture to self-organize into functional units and
organ-like systems. In some cases, pluripotent cells can be induced to
differentiate down independent pathways, leading to an organoid. In
others, interacting units can be generated, often from iPS cells, and
‘engineered’ to interact in a way that recapitulates certain aspects of
in vivo function or disease. Such models have tremendous potential both
to gain new insight into disease processes and for moderate throughput
drug screening. In this talk I will describe several models developed
in our lab including a neuromuscular junction, blood-brain barrier, and
vascularized skeletal muscle, addressing some of the design principles
they have in common, the future potential, and barriers to progress.
Add to Calendar ▼2018-06-05 00:00:002018-06-06 00:00:00Europe/LondonLab-on-a-Chip and Microfluidics Europe 2018Lab-on-a-Chip and Microfluidics Europe 2018 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
Add to Calendar ▼2018-06-05 11:15:002018-06-05 12:15:00Europe/LondonMicrophysiological Models Relying on Emergence of Multi-Cellular Engineered Living SystemsLab-on-a-Chip and Microfluidics Europe 2018 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
